Employers leaned on a variety of strategies to contain rising health costs this year, from passing them on to workers to moving away from traditional health plans altogether.

Amelia Kinsinger
Health costs continued to climb in 2026, biting into the budgets of both businesses and its workers.
The average premium for employer-sponsored family health coverage rose to $28,303 this year, up 5% from 2025, according to KFF, a nonpartisan health policy research, polling, and news organization. Meanwhile, the average annual worker contribution to a family health plan rose even more steeply, from $6,850 to $7,471—a 9% increase.
Whereas Cheryl King’s benefits-related conversations used to center around tweaking a deductible or out-of-pocket maximum, or upleveling certain perks, today those conversations have shifted to making sure “people can afford just their basic healthcare,” the chief people officer of HealthEquity, a tech firm that administers tax-advantaged health accounts like HSAs, said.
“The cost of your benefits increase, or projected increase, is going up faster than any other thing in the environment,” she said.
As health costs go up, employers are leaning on a variety of strategies to contain them—from passing on additional costs to workers, to limiting eligibility for certain drugs or moving away from traditional health plans altogether.
Passed on costs to employees. Though employers historically try to avoid passing on health costs to employees, this was the most common strategy companies turned to in response to higher health costs, according to KFF’s 2026 employer health benefits survey.
Some 18% of firms offering health benefits said they increased the share of the premium that employees contribute, while 17% said they increased deductibles or other cost-sharing for most services. The share of large firms offering health benefits employing these strategies was higher, at 44% and 21%, respectively.
Moved away from traditional health plans. Many HR teams continue to explore cost-effective alternatives to traditional group health plans.
One such alternative, now known as CHOICE arrangements, remains niche but is growing in popularity among some employers. CHOICE plans, which were previously known as ICHRAs, allow employers to reimburse workers so that they can buy health insurance on the individual marketplace.
More than 20,000 employers offered these arrangements as of January 2026, according to the HRA Council. That data showed CHOICE adoption doubling among large employers year over year. Still, overall takeup of these plans among employers already offering health benefits remains low, with just 4% providing ICHRA-like arrangements as of 2026, according to KFF.
Another option HR might consider to control costs is direct contracting, which allows employers to negotiate directly with providers, rather than insurance carriers, to design bespoke health plans for their workforces. The union 32BJ announced it would enter into a direct contract with New York-based Northwell Health at the end of last year, and said it expects to save $46 million in the first year from the switch.
Encouraged preventative care. While it can be challenging to incentivize employees to see a primary care physician on a regular basis, those who do typically see lower health costs, HR Brew previously reported.
Some companies now offer primary care on- or near-site in order to make these services more accessible to workers. The CHRO of one such company, Pella Corporation, told us he hoped opening a health clinic five minutes from the office would help them “really engage with those high-cost, high-risk members more over time.”
HealthEquity now ties health savings account (HSA) funding to employee’s preventative care usage, King said.
The thinking behind this approach is, “if we can get our workforce to do the things to be healthier, it will affect our overall benefit costs because people are healthier, which is also a good thing for performance and productivity in [our] organization.”
Reduced eligibility for costly drugs. The high cost of prescription drugs remain top-of-mind for benefits leaders, and are leading them to limit access to medications, in some cases.
GLP-1s for weight loss offer one of the clearest examples of this trend. Large employers including Starbucks and PwC rolled back coverage of these medications this year amid concerns about their costs. Deloitte will no longer cover the drugs for weight loss, Business Insider reported on Nov. 12, as the consulting firm told employees rising health costs have become “untenable.”
Despite efforts from both private and public sector players to lower the cost of GLP-1s, the retail list price for popular brands like Zepbound and Wegovy still hovers above $1,000 per month.
Nearly one-third (29%) of employers with 200 or more workers said GLP-1s for weight loss had a “significant” impact on their health plan’s prescription drug spending, per KFF’s 2026 survey.